Citation

Hilbert-Carius P, Schwarzkopf D, Reinhart K, Hartog CS, Lefering R, Bernhard M, Struck MF. Sci. Rep. 2018; 8(1): e11567.

Affiliation

Department of Anesthesiology and Intensive Care Medicine; University Hospital Leipzig, Leipzig, Germany. manuelstruck@web.de.

Copyright

(Copyright © 2018, Nature Publishing Group)

DOI

10.1038/s41598-018-30053-0

PMID

30068966

Abstract

The purpose of this study was to investigate the efficacy and safety of synthetic colloid resuscitation among severely injured patients. Fluid resuscitation of trauma patients of a nationwide trauma registry was analysed between 2002 and 2015. Effects of synthetic colloid resuscitation in the pre-hospital setting and emergency department on renal failure, renal replacement therapy and multiple organ failure were analysed among patients with ≥2 days intensive care unit stay, and in-hospital mortality was analysed among all patients. 48,484 patients with mean age of 49 years and mean injury severity score of 23 points were included; 72.3% were male and 95.5% had blunt trauma. Risk-adjusted analyses revealed that patients receiving >1,000 ml synthetic colloids experienced an increase of renal failure and renal replacement therapy rates (OR 1.42 and 1.32, respectively, both p ≤ 0.006). Any synthetic colloid use was associated with an increased risk of multiple organ failure (p < 0.001), but there was no effect on hospital mortality (p = 0.594). Between 2002 and 2015 usage of synthetic colloids dropped, likewise did total fluid intake and usage of blood products. The data from this analysis suggests that synthetic colloid resuscitation provides no beneficial effects and might be harmful in patients with severe trauma.

Language: en